AI SOC Strengthens Information Security & Realizes Digital Intelligence for Businesses CITIC Telecom International CPC Limited (CITIC Telecom CPC), a wholly-owned subsidiary of CITIC Telecom International Holdings Limited (HKG: 1883) is pleased to announce a triumph in winning two prestigious awards as 2026 unfolds, recognizing its cybersecurity and continuous innovation capabilities. CITIC Telecom CPC’s AI-driven Security Operations Centre (AI SOC) is honored “Best AI SOC Service Provider” in “IT PRO Corporate Choice Award 2025” from the well-known IT media . In addition, two security experts of CITIC Telecom CPC have won two accolades in “Internet and Cloud Services” sector of…
Author: Marie Jones
TOKYO//SINGAPORE, Feb 9, 2026 – (JCN Newswire) – JCB International Co., Ltd., the international operations subsidiary of JCB Co., Ltd., Japan’s only international payment brand, today announced a new collaboration with RESORTS WORLD AT SENTOSA PTE. LTD. (RWS), targeted at Japanese tourists. The partnership with RWS is designed to enhance the travel experience for Japanese visitors to Singapore. Located on Sentosa, Singapore’s premier resort island, Resorts World Sentosa is one of the nation’s leading integrated lifestyle destinations, welcoming millions of local and international visitors annually across its attractions, dining, entertainment and lifestyle offerings. This collaboration aims to curate meaningful experiences that…
Special Exhibition Confirmed for Hit Anime “Tensura,” with Second Film Set to Release This Winter! TOKYO, Feb 9, 2026 – (JCN Newswire) – Anime Tokyo Station is an anime exhibition site focused on Japanese anime content, which has developed a devout fan base around the world. The facility attracts visitors of all ages and has welcomed 253,236 guests from Japan and overseas (as of January 18, 2026). ©Taiki Kawakami, Fuse, KODANSHA/ “Ten-Sura” Anime Tokyo Station regularly hosts special exhibitions for popular anime. From February 21 (Sat.) to May 24 (Sun.), 2026, it will hold the “That Time I Got Reincarnated as a…
According to disclosure of interests filed with the Hong Kong Stock Exchange (HKEX), the Government of Singapore Investment Corporation (GIC) has acquired an initial stake in Ascletis Pharma (HKG: 1672). GIC purchased 64,128,000 shares at an average price of approximately HK$12.18 per share, representing a total investment of roughly HK$781 million (approx. US$100 million). This transaction marks the official entry of one of the world’s leading sovereign funds into Ascletis Pharma’s shareholder base, drawing market attention to the renewed positioning of global long-term capital in China’s innovative pharmaceutical sector. As one of the most representative sovereign funds globally, GIC’s investment…
Currently, digital transformation has become the core proposition of global industrial upgrading, and the manufacturing industry is also undergoing a disruptive transformation from being “experience-driven” to “data intelligence-driven”. In this process, the deep integration of artificial intelligence and industrial scenarios has become the key to resolving manufacturing complexity and unleashing productivity. The introduction of the Action Plan for Integrating and Empowering Industrial Internet and Artificial Intelligence by MIIT further marks the upgrade of “AI + Manufacturing” from an optional pathway to a mandatory one, giving rise to a blue ocean of value worth tens of trillions. As a deep participant…
According to the disclosure of interests information released by the Hong Kong Stock Exchange, on 5 February, GIC Private Limited made its first equity investment in Ascletis Pharma (01672) by acquiring 64,128,000shares at a price of HKD12.18per share, involving a total consideration of approximately HKD781.08million (equivalent to approximately USD100.01 million). Following the transaction, GIC’s shareholding in Ascletis Pharma amounted to 64,128,000shares, representing a shareholding percentage of 6.42%, marking GIC’s initial entry into the company’s shareholder base.
On February 6, Distinct Healthcare Holdings Limited (Distinct Healthcare or the Company, Stock Code: 2677.HK), a leading player in China’s mid-to-high-end consumer healthcare services market, was successfully listed on the main board of the Hong Kong Stock Exchange, emerging as a high-quality and rare private healthcare gem in the Hong Kong stock market. This marks the beginning of a new chapter in the Company’s scaled and high-quality development. On its debut, Distinct Healthcare delivered a standout debut, opening sharply higher at HK$81 per share (a 35.23% premium to the offer price), well above the offer price—an indication of strong capital…
Everest Medicines today announced that China’s National Medical Products Administration (NMPA) has approved VELSIPITY(R) (etrasimod arginine tablets) for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent. UC is a chronic, relapsing, non-specific inflammatory bowel disease. In China, the incidence and prevalence of UC are accelerating, with a clear trend toward younger patients. The patient population is projected to increase from approximately 0.98 million in 2025 to 1.50 million by 2031.There remains a critical need for therapies…
The accolades underscore Malaysia’s leading mineral water brand’s international achievements in their consistent pursuit of quality, excellence and industry leadership Spritzer Berhad (“Spritzer” or “the Company”), Malaysia’s leading natural mineral water brand started the year on a strong note with a repeat of the annual recognition by two prestigious platforms, the Putra Brand Awards 2025 and the Superior Taste Award 2025. These achievements, their 10th and 15th recognition for each award respectively, reinforce Spritzer’s continued efforts and commitment to excellence, innovation and uncompromising standards in delivering high-quality natural mineral water locally and internationally. Spritzer Wins the Gold at the Putra…
Eternal Beauty Holdings Limited (Eternal Beauty or the Group) (HKG: 6883), a pioneer in China’s beauty and fragrance industry, announced its first-ever collaboration with Lane Crawford, a premier luxury department store, to launch an exclusive boutique niche fragrance section at its Harbour City store in Tsim Sha Tsui. The collaboration aims to further advances the Group’s strategy focused on high-margin niche fragrance brands, strengthens its premium brand footprint through an elite retail network, and captures the growing profit opportunities in the niche fragrance for Chinese Mainland and Hong Kong markets. The zone brings together four international niche fragrance brands under…
On 6 February, Muyuan Foods Co., Ltd. (Muyuan Foods or the Company, Stock Code: 2714.HK), a global leader in the pork industry, officially listed on the Main Board of The Stock Exchange of Hong Kong Limited today, marking the beginning of a new chapter in the Company’s international development. Powerful Cornerstone Investors Underscore Muyuan’s Industry Leadership For this Hong Kong IPO, Muyuan Foods successfully attracted a prestigious lineup of cornerstone investors, including Charoen Pokphand Foods, Wilmar International Limited (Wii Pte. Ltd. and HPRY), Sinochem Hong Kong, Hong Kong Henan Agri International, FIL Investment, RBC Global Asset Management (Asia) Limited and…
Expanding production capacity by introducing automated equipment reduces manufacturing costs and shortens delivery times TOKYO, Feb 5, 2026 – (JCN Newswire) – TANAKA PRECIOUS METAL TECHNOLOGIES Co., Ltd. (Head Office: Chuo-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), a company engaged in the industrial precious metals business of TANAKA, announced today that it has established a total solution system capable of supporting all processes in the contract manufacturing business for various test kits including in vitro diagnostics. Until now, TANAKA has been responsible primarily for processes from developing and manufacturing test kits to bulk production of extraction buffer. At this time, TANAKA…
According to the disclosure of interests information released by the Hong Kong Stock Exchange, GIC Private Limited made its equity investment in Ascletis Pharma by acquiring 64,128,000shares at a price of HKD12.18per share, involving a total consideration of approximately HKD781.08million (equivalent to approximately USD100.01 million). Following the transaction, GIC’s shareholding in Ascletis Pharma amounted to 64,128,000shares, representing a shareholding percentage of 6.42%, marking GIC’s initial entry into the company’s shareholder base.
New Hard Pure Gold Pavilion showcases breakthrough gold technologies Organised by the Hong Kong Trade Development Council (HKTDC), the world’s largest one-stop jewellery marketplace will return in early March under its proven “Two Shows, Two Venues” format. The 12th Hong Kong International Diamond, Gem & Pearl Show will take place from 2 to 6 March at AsiaWorld-Expo and will feature a wide range of jewellery raw materials. Also, the 42nd Hong Kong International Jewellery Show will be held from 4 to 8 March at the Hong Kong Convention and Exhibition Centre and will showcase finished jewellery pieces. Jenny Koo, Deputy Executive Director of the…
Banle Group (Banle or the Group), a leading Asia-Pacific marine fuel logistics provider, hosted its landmark inaugural ESG Forum — Charting the New Horizon: Powering Green Shipping with Sustainable Fuels — uniting top maritime executives, financiers, legal experts, and climate scientists to address the shipping industry’s urgent decarbonization challenges on February 2. Speaker Lineup Tackles Critical Issues The forum featured exclusive insights from: Dr. Teck Lim Chia, Chairman and CEO of Banle Group Ms. Karen Cheah Yee-Lynn, Independent Director of Banle Group, Partner of Chooi & Company, Immediate Past President of the Malaysian Bar and EXCO Member of LAWASIA Mr.Matt…
Annature, Australia’s leading eSignature and Identity verification provider, has announced the release of its 21 CFR Part 11 compliant electronic signature module, enabling organisations operating in FDA‑regulated environments to execute electronic records with confidence. The new capability ensures Annature customers can meet the U.S. Food and Drug Administration’s requirements for electronic records and electronic signatures under 21 CFR Part 11, a regulation that governs data integrity, signer authentication, and auditability across industries such as life sciences, pharmaceuticals, biotechnology, and clinical research. The release has been driven by growing demand from U.S.-based and multinational organisations seeking a modern, compliant alternative to…
Everest Medicines (HKG: 1952, Everest, or the Company), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into an exclusive license agreement with Shaanxi Micot Pharmaceutical Technology Co., Ltd. (Micot) to commercialize MT1013, the world’s first-in-class dual-targeting receptor agonist polypeptide that simultaneously targets the Calcium-Sensing Receptor (CaSR) and the Osteogenic Growth Peptide (OGP) receptor and is primarily developed with Secondary Hyperparathyroidism (SHPT) as its leading indication, in China and Asia-Pacific (excluding Japan). According to the agreement, Everest Medicines will pay Micot an upfront payment of RMB 200 million…
Industry recognition for the third consecutive year reinforces AGFA HealthCare’s clinician-first commitment, and leadership in empowering connected, high-performance imaging environments AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company’s continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare’s Best in KLAS distinctions reflect strong customer validation of its…
NEW YORK, TAIPEI and TOKYO, Goldenstone Acquisition Limited (Ticker: GDST) (“Goldenstone”), a special purpose acquisition company listed in the U.S. capital market, today announced the execution of a letter of intent (LOI) for a proposed business combination with Deluxe Technology Group (“Deluxe”), a Taiwan-based leader in green technology machinery and sustainable material solutions. The merger is poised to capitalize on the rapidly growing sustainable packaging market, which is projected to reach over $250 billion by 2035. Amidst a complex global regulatory landscape and increasing consumer demand for eco-friendly products, Deluxe has distinguished itself by developing a proprietary and vertically integrated…
Military Metals Corp. (CSE: MILI) (OTCQB: MILIF) (FSE: QN90) (the “Company” or “MILI”) is pleased to report the additional analytical results of the Company’s definition drilling campaign at the 100% owned flagship Trojárová Antimony-Gold Project (the “Project”) in Slovakia as announced on November 4, 2025. The 2025 drilling campaign was designed to confirm historical drilling results and to support SLR Consulting’s work towards establishing a current mineral resource estimate on the Project, which the company anticipates delivery of by the end of Q1, 2026, further discussed in the Company’s January 9, 2025 announcement. These priority assay results represent the main mineralized zone from the…